Skip to content

October 22, 2025

A Fully Automated and Highly Customizable Technology that Solves the Complexities of Bioprocessing

Unlock the power of possibilities
with a single piece of equipment
capable of running all
downstream unit operations
across multiple scales.

October 22, 2025

Solving the Complexities of Bioprocessing by Simplifying Material Demand and Scale-up

Bioprocessing with SymphonX integrates elegant point-of-use in-line buffer make-up and dilution. Learn more.

October 22, 2025

A Modular and Multi-Functional Purification Strategy

Designed for multi-product and multi-process cGMP facilities, SymphonX™ performs standalone batch processing or integrated and continuous biomanufacturing as part of our MaruX solution. Read more…

October 22, 2025

2024-2025 Sustainability Review

Discover our 24-25 Sustainability Review that dives into our vision and progress on initiatives related to climate impact reduction, circular economy, employee safety and workplace…

October 20, 2025

Shaping the Future of Microbial Development: From Gene to GMP

Join us to discover how smarter, faster process development can help you bring therapies to patients more effectively.

October 1, 2025

MaruX™: Simplified Continuous Biomanufacturing

Learn about MaruX - FUJIFILM Biotechnologies' transformative platform for end-to-end monoclonal antibody production.

October 1, 2025

Meet MaruX™: Setting the Standard for End-to-End Continuous Biomanufacturing

The MaruX platform radically reimagines continuous manufacturing by automating and integrating both upstream and downstream processes.

September 30, 2025

September 2025 Newsletter

Read up on FUJIFILM Biotechnologies' September 2025 IN FOCUS Newsletter.

September 19, 2025

August 2025 Newsletter

Read up on FUJIFILM Biotechnologies' August 2025 IN FOCUS Newsletter.

August 13, 2025

FUJIFILM Biotechnologies Large Molecule Capacity Update: July 2025

Harry Bushill, Commercial Development Director, shares how our expertise in microbial strain & process development enables our partners to swiftly progress to GMP.